Clinical Trials in New York

Showing 6581-6600 of 22,668 trials

A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC

NCT06010329

The main objective of the study will be to evaluate the efficacy of sutetinib maleate capsules in participants with locally advanced or metastatic non-small cell lung cancer NSCLC (uncommon EGFR mutations only).

Non-small Cell Lung Cancer

Teligene US66 participantsStarted Dec 2023

Glendale, California, United States • La Jolla, California, United States • Tampa, Florida, United States +6 more locations

COMPLETEDPhase 3< 1 mile

ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D

NCT00490139

This was a four-arm (parallel group) randomized, open-label, multicenter Phase 3 study to investigate the use of a combination of Lapatinib and Trastuzumab, a sequence of Trastuzumab followed by Lapatinib, and Lapatinib alone, compared to Trastuzumab alone in the adjuvant treatment of Human Epidermal Growth Factor Receptor 2 (HER2) positive early breast cancer.

Neoplasms, Breast

Novartis Pharmaceuticals8,381 participantsStarted May 2007

Mobile, Alabama, United States • Anchorage, Alaska, United States • Tucson, Arizona, United States +921 more locations

A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC

ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D

Find Trials by Condition in New York

Postpartum Continuous Glucose Monitoring (CGM) Study

Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in Non-small Cell Lung Cancer (NSCLC) With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer (CRC)

Study of ORIC-533 in Relapsed or Refractory Multiple Myeloma

A Study of Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnT

EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study

18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies

Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-3)

Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)

Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

PF-06863135 As Single Agent And In Combination With Immunomodulatory Agents In Relapse/Refractory Multiple Myeloma

APR-246 & Azacitidine for the Treatment of TP53 Mutant Myelodysplastic Syndromes (MDS)

Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors

A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer

7-Day Trial of Sucraid for Alleviating CSID Symptoms in Subjects With Low, Moderate, and Normal Sucrase Levels

Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy

Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease

Study of Magrolimab Combinations in Participants With Myeloid Malignancies